These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2400738)

  • 1. The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats.
    Anğ O; Güngör M; Aricioğlu F; Inanç D; Sağduyu H; Uysal V; Küçüker M
    Int J Exp Pathol; 1990 Aug; 71(4):507-11. PubMed ID: 2400738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats.
    Koyuncuoğlu H; Güngör M; Anğ O; Inanç D; Anğ-Küçüker M; Sağduyu H; Uysal V
    Infection; 1988; 16(1):42-5. PubMed ID: 3360496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staphylococcal infection as a predisposing factor in experimental colipyelonephritis].
    Breunung M; Breunung MM; Peschel HG
    Padiatr Padol; 1971 Mar; 6(1):58-74. PubMed ID: 4949645
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the risk of pyelonephritis due to desmopressin in rats with cystitis?
    Gunes D; Kavukcu S; Yilmaz O; Sarioglu S; Baskin H; Soylu A; Ormen M; Turkmen M
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):703-6. PubMed ID: 17235415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental staphylococcal pyelonephritis in mice].
    Breunung M; Richter H; Peschel HG
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):73-88. PubMed ID: 5386254
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of parenteral iron preparations on experimental pyelonephritis.
    Fletcher J; Goldstein E
    Br J Exp Pathol; 1970 Jun; 51(3):280-5. PubMed ID: 4913857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental pyelonephritis in rats.
    Mehrotra RM; Pande CL; Chaturvedi UC
    Indian J Med Res; 1976 Mar; 64(3):459-71. PubMed ID: 786871
    [No Abstract]   [Full Text] [Related]  

  • 8. A model of experimental acute hematogenous pyelonephritis in the rat.
    Tancheva S; Valcheva-Kuzmanova SV; Radev RZ; Marinov MD; Boychev B; Stoeva T; Boyadjieva SK; Nenov KS
    Folia Med (Plovdiv); 2011; 53(2):63-8. PubMed ID: 21797109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iron on acute pyelonephritis and later chronic changes.
    Guze LB; Guze PA; Kalmanson GM; Glassock RJ
    Kidney Int; 1982 Jun; 21(6):808-12. PubMed ID: 6752529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis.
    Imamoğlu M; Cay A; Cobanoglu U; Bahat E; Karahan C; Tosun I; Sarihan H
    Urology; 2006 Jun; 67(6):1315-9. PubMed ID: 16697444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary pyelonephritis (the focal problem)].
    Rényi-Vámos F; Balogh F
    Z Urol Nephrol; 1979 Aug; 72(8):581-8. PubMed ID: 388921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental pyelonephritis--a histopathological study of blood borne and ascending patterns of infection.
    Prakash C; Gupta RR
    J Assoc Physicians India; 1975 Jul; 23(7):409-13. PubMed ID: 1104567
    [No Abstract]   [Full Text] [Related]  

  • 15. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats.
    Sener G; Tuğtepe H; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC
    J Pineal Res; 2006 Oct; 41(3):220-7. PubMed ID: 16948782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats.
    Raffel L; Pitsakis P; Levison SP; Levison ME
    Infect Immun; 1981 Dec; 34(3):773-9. PubMed ID: 6800956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of staphylococcal pyelonephritis in rats with N-formimidoyl thienamycin.
    Guze PA; Kalmanson GM; Ishida K; Freedman LR; Guze LB
    Chemioterapia; 1984 Feb; 3(1):53-6. PubMed ID: 6598578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous heme on hepatic iron-load and changes induced in hepatic heme metabolism by chronic iron-load.
    Volin L; Vuori E; Tenhunen R
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):423-38. PubMed ID: 2727392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute experimental pyelonephritis. Treatment with tobramycin. Influence of the rhythm of administration on efficacy and renal tolerability].
    Herscovici L; Lemeland JF; Dalion J; Olier B; Fillastre JP
    Pathol Biol (Paris); 1984 May; 32(5):450-4. PubMed ID: 6739154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.